drug screening

MIT researchers developed a groundbreaking framework for drug screening that significantly reduces time and costs associated with testing drugs on biological models, such as pancreatic cancer and immune cells. By analyzing multiple drugs simultaneously, the new method allows scientists to identify each compound’s specific effects using computational analysis. This framework promises a faster, more efficient way to screen drugs, potentially speeding up new drug discoveries and benefitting medical research.